Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain
Merck(US:MRK) Investorsยท2025-10-30 13:43TRENDING: You Don't Have To Dig Far To Cash In On Rare Earths Dow Jones stock Merck (MRK) topped third-quarter forecasts on Thursday, but shares skidded as its challenges with vaccine Gardasil continued. Gardasil demand is sliding in China. In total, sales of the human papillomavirus vaccine tumbled 24% to $1.75 billion. That just beat forecasts for $1.72 billion. Excluding China, sales declined just 2%. Merck widely beat third-quarter expectations and raised its 2025 profit guidance. But the company also n ...